FDA Inspection 1203279 — Brigham and Women's Hospital, Inc., The
The FDA completed an inspection of Brigham and Women's Hospital, Inc., The on April 11, 2023 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 11, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Boston, MA (United States)